Director, Office of Health Plan Standards and Compliance Assistance

1210-AC07 202110 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 1210 Employee Benefits Security Administration EBSA 1200 Department of Labor DOL Requirements Related to Prescription Drug Reporting

This rule would implement the prescription drug reporting requirements that apply to group health plans and health insurance issuers offering coverage in the group and individual markets under section 204 of title II of Division BB of the Consolidated Appropriations Act.

]]> Economically Significant Previously Published in The Unified Agenda Final Rule Stage Undetermined Undetermined 29 CFR 2590.716-1 29 CFR 2590.716-2 29 CFR 2590.725-1 to 2590.725-4 Pub. L. 116-260, Division BB, Title I and Title II No Request For Information (RFI) 06/23/2021 86 FR 32813 RFI Comment Period End 07/23/2021 Interim Final Rule 11/23/2021 86 FR 66662 Interim Final Rule Effective 12/23/2021 Interim Final Rule Applicability Date 12/27/2021 Interim Final Rule Comment Period End 01/24/2022 Undetermined Local State Yes No No No 1545 Internal Revenue Service IRS Joint 0938 Centers for Medicare & Medicaid Services CMS Joint Amber Rivers Director, Office of Health Plan Standards and Compliance Assistance 1210 Employee Benefits Security Administration EBSA 202 693-8335 rivers.amber@dol.gov 200 Constitution Avenue NW, Washington DC 20210